#United States #New York #Gross Law Firm #Treace Medical #TMCI

Treace Medical Concepts Shareholders Alerted for Class Action Lawsuit

In recent news, shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have been notified by The Gross Law Firm about the initiation of a class action lawsuit that directly affects them. This notice serves as a crucial reminder for shareholders who purchased shares of TMCI between May 8, 2023, and May 7, 2024, to consider their legal options. Shareholders are encouraged to reach out to The Gross Law Firm to determine their eligibility for lead plaintiff status in this matter.

Key Details

Class Action Timeline

The class action was announced following serious allegations that Treace Medical Concepts engaged in practices that misled investors. The complaint alleges that during the defined class period, the company issued materially false statements and failed to disclose critical facts regarding its primary product, the 3D bunion correction system branded as 'Lapiplasty.' High competition in the bunion correction market allegedly impacted the demand for this product, leading to a decline in the company's revenue. Furthermore, the company reportedly needed to expedite the development of an alternative product to traditional surgical options, indicating a significant shift in their business strategy.

These revelations have raised concerns among investors, casting doubt on the company's previous optimistic statements about its business operations and future potential, which appear to have lacked a reasonable factual basis.

Next Steps for Investors

Shareholders who qualify under the class period are strongly urged to register their information with The Gross Law Firm. By doing so, they will gain access to portfolio monitoring software that provides real-time updates on the status of the case, ensuring they remain informed throughout the legal proceedings.

It is important to note that the deadline to apply for lead plaintiff status is June 10, 2025. Participation in this lawsuit does not require appointment as lead plaintiff and comes at no cost or obligation to the shareholders involved.

Why Choose The Gross Law Firm?

The Gross Law Firm stands out as a nationally recognized entity specializing in class action lawsuits, dedicated to defending the rights of investors. The firm operates on the principle of protecting investors from fraudulent activities that stem from deceptive business practices. They are committed to ensuring that corporations maintain ethical conduct and engage in responsible corporate citizenship. Their mission extends to recovering losses experienced by investors due to misleading statements or the failure to disclose vital information that could result in an inflated stock price.

How to Contact

For shareholders seeking information regarding the lawsuit or assistance in registering for participation, they can contact The Gross Law Firm through their official channels:

• - Email: info@grosslawfirm.com
• - Phone: (646) 453-8903
• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018.

This ongoing situation spells potential legal ramifications for Treace Medical Concepts and its shareholders. Those affected should act promptly to secure their involvement in this class action suit and safeguard their investment interests.